𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hematoporphyrin-based photodynamic therapy for cutaneous squamous cell carcinoma in cats

✍ Scribed by Isabelle Ferreira; Sheila C. Rahal; Noeme S. Rocha; Ana H. Gouveia; Thais P. Corrêa; Yuri K. Carvalho; Vanderlei S. Bagnato

Book ID
110871748
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
776 KB
Volume
20
Category
Article
ISSN
0959-4493

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Photodynamic therapy of facial squamous
Photodynamic therapy of facial squamous cell carcinoma in cats using a new photosensitizer
✍ Magne, Michael L.; Rodriguez, Carlos O.; Autry, Susan A.; Edwards, Benjamin F.; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB 👁 1 views

Background and Objective: Photodynamic therapy has been shown to be an effective treatment modality for surface-oriented neoplasms of the skin, respiratory, gastrointestinal, and urogenital systems. The purpose of this study was to assess the safety and efficacy of photodynamic therapy using a new p

mTHPC-mediated photodynamic therapy for
mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma
✍ Colin Hopper; Alexander Kübler; Harry Lewis; I. Bing Tan; Graham Putnam; the Fos 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 374 KB

## Abstract Surgery and radiotherapy are standard treatments for early oral squamous cell carcinoma, both resulting in good tumour control. However, neither of these modalities is without consequent functional or cosmetic impairment, and there are patients in whom both are contraindicated. Furtherm

Photodynamic therapy outcome for T1/T2 N
Photodynamic therapy outcome for T1/T2 N0 oral squamous cell carcinoma
✍ Waseem Jerjes; Tahwinder Upile; Zaid Hamdoon; Charles Alexander Mosse; Mira Morc 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

## Abstract ## Introduction This new prospective clinical study assessed the oncological outcomes following surface illumination mTHPC‐photodynamic therapy of T1/T2 N0 oral squamous cell carcinoma (OSCC) patients. ## Material/Methods Thirty‐eight patients participated in this study. Their mean a